The Funding Map Changed
If you are a tech startup looking for non-dilutive funding in July 2026, the first question is not "which grant is biggest?" It is which mechanism matches the company, technology, and next milestone. The SBIR and STTR authorization lapse ended on April 13, 2026, when the President signed S. 3971. The Small Business Administration says the law reauthorized both programs through September 30, 2031. That restores the statutory program; it does not make every agency's archived notice active. A startup still needs a current solicitation and must follow that agency's ownership, topic, submission, and security rules. Other lanes remain important. Defense and civilian agencies use BAAs, prototype agreements, prizes, direct contracts, and research grants. States run commercialization, matching, and sector programs. Federal tax rules can change the after-tax cost of R&D but are not the same as a cash award and should be reviewed with a qualified tax adviser. Build a stack around the next evidence the company must produce: feasibility, prototype, customer validation, regulatory evidence, manufacturing scale-up, or deployment. Do not force one program to pay for a stage it was not designed to fund. For the full SBIR reauthorization status, see our dedicated guide. For R&D funding beyond SBIR, see our BAA and OTA guide.
SBIR/STTR: Where Things Actually Stand
S. 3971, the Small Business Innovation and Economic Security Act, was signed on April 13, 2026. The White House signing notice and SBA both state that it authorizes SBIR, STTR, and related pilot programs through fiscal year 2031. For an applicant, authorization and availability are different facts. An agency must publish a current solicitation or notice, define its topics and dates, and provide the submission route. Old NIH, NSF, DOE, or DoD notices from the lapse do not become open because the law changed. Start with the agency's current program page and the controlling notice. Existing awardees should also read the current follow-on rules rather than assume an older amount or rolling window remains in force. Phase III, Direct-to-Phase II, transition, and matching opportunities depend on the agency, award history, and current notice. A first-time applicant should prepare the durable parts now: SAM.gov registration where required, the SBA Company Registry record, ownership and affiliation analysis, a focused technical objective, commercialization evidence, and a search for an agency topic that actually fits. The strongest application is not a generic startup pitch. It is a response to a named public problem with a feasible research plan.
🔍 Search related opportunities now
Defense Innovation: Where the Money Moved
Defense and dual-use startups have several distinct entry points. DoD SBIR/STTR topics are active again, but the company still needs a current topic and must satisfy the small-business program's rules. DARPA's current SBIR/STTR topic page explicitly notes the April 2026 reauthorization and links active announcement topics. The Defense Innovation Unit uses Commercial Solutions Openings and Other Transaction authority for commercial technology that addresses a posted defense problem. DIU's open-solicitations page shows the current problem statements, response dates, eligibility, and submission requirements. DIU says its process often awards within 60 to 90 days, but that is a program description, not a promise for every solicitation. DARPA BAAs, service-laboratory notices, AFWERX opportunities, prototype consortia, prizes, and direct contracts use different gates. STRATFI, TACFI, and Phase III are not generic alternatives available to every new company; eligibility can depend on an existing award, transition partner, matching funds, or a current notice. Choose by maturity. DIU generally looks for commercially viable technology responsive to a named problem. A BAA may fund earlier research. SBIR/STTR topics use agency-defined phase and commercialization requirements. A direct production contract expects a deliverable capability. See the defense contracts guide for procurement fundamentals, then verify every current opportunity at its official source.
Tax Benefits Are a Separate Finance Lane
The One Big Beautiful Bill Act changed the tax treatment of domestic research costs, qualifying property, Section 179 expensing, and qualified small-business stock. Those provisions can affect runway and investor outcomes, but a deduction or exclusion is not a grant and may have no immediate cash value for a company without the relevant tax liability. Section 174A generally restored immediate deduction of eligible domestic research or experimental expenditures, while foreign research follows different treatment. Bonus depreciation, Section 179 limits, and qualified small-business-stock rules each have their own dates, definitions, elections, and transition provisions. Do not turn a headline amount into a forecast without applying the law to the company's records and tax posture. The research-credit payroll offset is a different provision. The IRS research payroll-credit guidance says the annual maximum increased from $250,000 to $500,000 for tax years beginning after December 31, 2022 under the Inflation Reduction Act. OBBBA did not create that increase. A qualified small business must satisfy the gross-receipts tests, calculate a valid research credit, make the required election, and claim it through the applicable tax and payroll filings. Use a qualified tax professional to evaluate eligible costs, documentation, elections, amended-return options, payroll timing, and interactions with grant or contract accounting. For details on keeping public-award costs separate and supportable, see the grant budget guide.
What's Still Open Outside Defense
A startup should search beyond SBIR when another mechanism better matches the work. NSF I-Corps focuses on customer discovery rather than product-development funding. ARPA-E uses topic-specific energy programs. ARPA-H uses program and mission-office solicitations for health breakthroughs. DARPA and service laboratories publish BAAs for stated research needs. CHIPS programs can address semiconductor research, facilities, or supply-chain goals under different notices and terms. None of those names is evidence that an application is open today. Program pages can describe recurring activity while the actual solicitation is closed. Search current records, then open the primary notice and confirm the date, applicant type, technical topic, award instrument, cost share, intellectual-property terms, and submission stage. For energy sector startups, compare grants with loans, tax incentives, and state programs rather than treating them as interchangeable. For federal R&D, search current BAAs and contracts.
State Programs Can Fill a Specific Gap
State programs can reimburse proposal costs, match a federal Phase I award, support university translation, lend company-development capital, or provide a tax benefit. Those instruments are not interchangeable, and many state rounds are short. North Carolina illustrates the distinction. Its One North Carolina Small Business Program has separate Phase I proposal-incentive and federal-award matching programs. The fiscal year 2026 round closed June 30, so it is a monitor item until the state posts a new solicitation. Separately, the North Carolina Biotechnology Center lists fiscal year 2027 research grants and company loans with August, September, and October dates. A company loan should not be counted as grant revenue. See the current North Carolina funding guide for verified examples. For any state, use the administering agency's current page and answer five questions: Is the program accepting applications now? Is a federal award or in-state location required? Is the money a grant, reimbursement, tax benefit, loan, or investment? What costs and dates are eligible? Can it be combined with the federal award without charging the same cost twice? Build a stack only after those answers are documented. Several smaller programs do not automatically equal an SBIR award, and a tax benefit with no current tax value does not extend runway like cash.
Practical Steps Based on Where You Are
What to do depends on the next milestone. If you are proving technical feasibility, search current SBIR/STTR topics and BAAs that name the public problem your research addresses. Compare eligibility, technical scope, data rights, and required deliverables before choosing. If you are building a defense or dual-use prototype, compare the current SBIR solicitation with DIU, DARPA, service-lab BAAs, and applicable prototype consortium opportunities. Do not quote an old 60-day timeline or award range as a promise; the current notice controls. Register on SAM.gov where the route requires it. If you are in energy, health, biotechnology, or semiconductors, search the relevant agency and state programs by technical problem. ARPA-E, ARPA-H, PCORI, BARDA, CHIPS, and state agencies use different award instruments and readiness expectations. See our healthcare funding guide for the health lane. If you are still validating the market, customer-discovery or state commercialization support may be a better fit than a research award. If you already hold an SBIR/STTR award, verify current Phase II, Phase III, transition, and state-match rules for that award and agency. Treat tax benefits as a separate finance decision. Eligibility and timing depend on the company's facts, so use a qualified tax adviser rather than counting a projected credit as awarded funding. Search startup and innovation funding on Funding Landscape